Researchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib showed promising activity suppressing cancer growth not only within the lungs but also in brain metastases for patients ...
Jun 16, 2023
0
28
Lung mesenchymal cells, which are critical components of the lung's unique structure, also play important roles in disease and recovery from injury, yet knowledge is limited about their biology or how they initiate diseases ...
Jun 13, 2023
0
37
A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial results presented on Sunday.
Jun 5, 2023
0
91
Cancer is no longer incurable. Nevertheless, according to data released by Statistics Korea last year, cancer remained the primary cause of mortality in Korea in 2021. This highlights the ongoing struggle against cancer, ...
Apr 4, 2023
0
21
Immune checkpoint inhibitors that activate T cells to target cancer cells have greatly improved patient outcomes across a variety of tumor types. But not all patients respond to the therapies. Moffitt Cancer Center researchers ...
Feb 13, 2023
0
10
The best treatment for a genetically driven form of lung cancer continues to show lasting benefits, a new clinical trial update shows.
Feb 6, 2023
0
2
A study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Cell Biology, details a previously unexplained type of cell death called disulfidptosis that could open the door for ...
Feb 6, 2023
0
36
Northwestern Medicine investigators have revealed new insights into how cancer cells can change their form by undergoing phenotypic "switches" to facilitate tumor growth and treatment resistance in small cell lung cancer, ...
Jan 11, 2023
0
49
Lung cancer is a leading cause of death in Japan and across the globe. Among all the cancers, lung cancer has one of the lowest five-year survival rates. Smoking tobacco and using tobacco-based products is known to heavily ...
Dec 28, 2022
0
99
Pancreatic cancer remains one of the deadliest malignancies worldwide. Since five-year survival rate for pancreatic ductal adenocarcinoma (PDAC) is only about 3% in patients, PDAC is very difficult to treat with surgery worldwide. ...
Dec 15, 2022
0
31
